The challenge of non-transplant eligible, newly diagnosed multiple myeloma.
This meta-analysis of randomized studies up to February 2025 evaluated first-line treatment strategies in newly-diagnose...
Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology).
- Post category:Hematologic Cancers
- Reading time:1 min read
This study analyzed 2,823 adult AML patients from the US and Germany, assessing molecular genetic features and outcomes...
Medical Imaging and Pediatric and Adolescent Hematologic Cancer Risk.
- Post category:Hematologic Cancers
- Reading time:1 min read
This large retrospective cohort study followed over 3.7 million children born between 1996 and 2016 across U.S. and Cana...
Impact of best response to ibrutinib plus Bendamustine and rituximab on PFS in MCL: a secondary analysis of SHINE.
- Post category:Hematologic Cancers
- Reading time:1 min read
The publication reports a secondary efficacy analysis from the phase 3 SHINE study evaluating ibrutinib combined with be...
Thiotepa-busulfan-fludarabine compared to clofarabine-based conditioning for haploidentical transplant with posttransplant cyclophosphamide in patients with myeloid malignancies: a retrospective study from the SFGM-TC.
- Post category:Hematologic Cancers
- Reading time:1 min read
The study retrospectively compared two reduced-intensity conditioning (RIC) regimens, Clofarabine-Baltimore (CloB) and T...